Cargando…
Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model
Neuromyelitis optica (NMO) is an autoimmune inflammatory demyelinating disease that mainly affects the spinal cord and optic nerve, causing blindness and paralysis in some individuals. Moreover, NMO may cause secondary complement-dependent cytotoxicity (CDC), leading to oligodendrocyte and neuronal...
Autores principales: | Zhang, Yuanyuan, Tian, Kewei, Jiang, Hong, Wang, Beibei, Han, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835265/ https://www.ncbi.nlm.nih.gov/pubmed/29670463 http://dx.doi.org/10.1155/2018/4187347 |
Ejemplares similares
-
C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
por: Chen, Haohao, et al.
Publicado: (2019) -
Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013) -
Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)